Inactive Instrument

Press Releases Adherex Technologies Inc. (USA) Other OTC

Equities

CA00686R4089

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-15	HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	MT
05-14	Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Fennec Pharmaceuticals : Corporate Presentation May 2024	05-15	PU
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update	05-14	GL
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024	05-07	GL
Fennec Pharmaceuticals : Corporate Presentation March 2024	03-30	PU
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update	03-21	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	03-19	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	03-19	AQ
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	03-17	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	02-29	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	02-29	AQ
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	02-01	GL
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	02-01	AQ
Fennec Announces Incremental $5 Million Investment from Petrichor	12-05	GL
Fennec Announces Incremental $5 Million Investment from Petrichor	12-05	AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	11-09	GL
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	11-09	AQ
Fennec Pharmaceuticals : Corporate Presentation November 2023	11-06	PU
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	11-06	GL
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	11-06	AQ
Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions	23-10-31	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Adherex Technologies Inc. (USA) Other OTC

Equities

CA00686R4089

Press Releases

Filters